 |
|
Publications and Presentations
Melanie Goldfarb, MD
- Evaluation and Management of Pediatric Thyroid Nodules
InTech, March 2012
View/download PDF file,
308KB
- Serving Adolescents and Young Adults:
What We're Doing at USC and Other Institutions in the U.S.
Presented by Dr. Melanie Goldfarb
View/download Powerpoint Presentation (.pptx file, 3.32MB)
- Normocalcemic parathormone elevation after successful parathyroidectomy:
Long-term analysis of parathormone variations over
10 years
Surgery, September 2011
The long-term significance of normocalcemic parathormone elevation (NPE) after
successful parathyroidectomy for sporadic primary hyperparathyroidism remains unclear.
View/download PDF file,
134KB
- Surgeon-performed ultrasound can
predict benignity in thyroid nodules
Surgery, September 2011
Up to 70% of people may harbor thyroid nodules
on routine screening.1 This includes the increasing
number of patients referred for nonpalpable
thyroid nodules found incidentally on imaging
studies for other unrelated health issues.
View/download PDF file, 236KB
- Resident/fellow assistance in the
operating room for endocrine surgery
in the era of fellowships
Surgery, December 2010
Historically, a high percentage of endocrine surgical procedures are performed by general
surgeons in nonteaching environments. With the institution of accredited fellowships, we sought to
determine whether that dynamic is changing.
View/download PDF file, 127KB
- Minimally invasive surgery and cancer: controversies part 1
Surgical Endoscopy, 2010
Perhaps there is no more important issue in the
care of surgical patients than the appropriate use of minimally
invasive surgery (MIS) for patients with cancer.
Important advances in surgical technique have an impact
on early perioperative morbidity, length of hospital stay,
pain management, and quality of life issues, as clearly
proved with MIS. However, for oncology patients, historically,
the most important clinical questions have been
answered in the context of prospective randomized trials.
View/download PDF file, 616KB
- Medical and Surgical Risks in Thyroid
Surgery: Lessons from the NSQIP
Annals of Surgical Oncology, February 2010
To assess whether perioperative surgical
outcomes associated with thyroid operations were different
in those with benign or malignant conditions, we queried
the NSQIP, a multi-institutional, risk-adjusted, prospective
U.S. database.
View/download PDF file, 566KB
- Synchronous parathyroid carcinoma, parathyroid
adenoma, and papillary thyroid carcinoma in a patient with severe and longstanding hyperparathyroidism
Endocr Pract. 2009 ; 15(5): 463–468. doi:10.4158/EP09075.CRR.
Primary hyperparathyroidism (HPT) is caused by parathyroid carcinoma in less than 1% (1,2). Coexistent thyroid carcinoma in these patients is extremely rare, and to our knowledge, only 5 patients with documented synchronous parathyroid and thyroid carcinomas have been reported (3-7).
View/download PDF file, 2.95MB
Stephen F. Sener, MD
- Ductal Carcinoma In Situ (DCIS) of the Breast:
Perspectives on Biology and Controversies in Current Management
Journal of Surgical Oncology, 2012
With the implementation of widespread screening mammography
in the 1980s and the increasing use of highly sensitive imaging modalities,
such as magnetic resonance imaging (MRI), the incidence of
ductal carcinoma in situ (DCIS) has increased considerably over the
past several decades. Thus, there are pressing questions regarding
optimal management.
View/download PDF file, 111KB
- Accuracy of Predicting Axillary Lymph Node Positivity
by Physical Examination, Mammography, Ultrasonography,
and Magnetic Resonance Imaging
Annals of Surgical Oncology, January 2012
Axillary lymph node status continues to be
among the most important prognostic variables regarding
breast cancer survival. We were interested in our ability to
accurately predict axillary nodal involvement by using
physical examination and standard breast imaging studies
in combination.
View/download PDF file, 271KB
- Neoadjuvant Therapy for Breast Cancer
Journal of Surgical Oncology, 2010
The past few decades have seen an increase in both the role and the complexity of neoadjuvant therapy for breast cancer. Neoadjuvant therapy was
initially described as systemic chemotherapy for inflammatory or locally advanced breast cancer but now entails a combination of chemotherapy,
endocrine therapy, and targeted therapy.
View/download PDF file, 116KB
- The effects of hormone replacement therapy on
postmenopausal breast cancer biology and survival
The American Journal of Surgery, 2009
The goal of this study was to compare the characteristics of breast cancers and
survival rates in HRT users versus nonusers.
View/download PDF file, 88KB
- Neoadjuvant Therapy for Locally Advanced Cancer
Journal of Surgical Oncology, November 2009
Neoadjuvant therapy was initially designed to preoperatively treat
locally advanced cancers with chemotherapy, but contemporary
concepts have come to include chemo-, radiation, endocrine, and
targeted therapies. In addition to impacting the options for surgical
treatment, either by facilitating organ-preserving resection or by
rendering a tumor resectable at all, neoadjuvant therapy has other
potential benefits.
View/download PDF file, 33KB
- Melanoma: Clinical Practice Guidelines in
Oncology
Journal of the National Comprehensive Cancer Network, March 2009
In 2008, an estimated 62,480 new cases of melanoma
will have been diagnosed and approximately 8420
patients will have died of the disease in the United
States.1 However, these projections for new cases
may represent a substantial underestimation, because
many superficial and in situ melanomas treated in the
outpatient setting are not reported.Description
View/download PDF file, 1.66MB
- Survival rates for breast cancers detected in a community service
screening mammogram program
American Journal of Surgery, August 2005
From 1994 through 2001, data on 1237 patients with breast cancer were collected concurrent with definitive surgical treatment
and entered into a comprehensive database.
View/download PDF file, 111KB
|
 |
|
 |
|
|
 |
 |
 |
SECTIONS
ADDRESS
University of Southern California
Upper G.I. and General Surgery
1510 San Pablo St. #514
Los Angeles, Ca 90033
Phone: (323) 442-6868
Fax: (323) 442-5877
|
 |
 |
|
 |
|
|